Loading companies…
Loading companies…
United States · Healthtech · Biotech · Hardware
Developing a nanoparticle platform for local dual-drug delivery during catheter-based vascular interventions
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | >$31M | S3 Ventures — Role not disclosedT45 Fund — Role not disclosed |